Monoclonal Antibodies
Anti-IGFBP1 Monoclonal Antibody for WB, ELISA - P08833
Item Number : CM0002865
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human
- Protein Weight
- 28kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | IGFBP1 Rabbit mAb |
| Remarks/Alias | AFBP, IBP1, PP12, IGF-BP25, hIGFBP-1, IGFBP1 |
| Species | Human |
| GeneID (Human) | 3484 |
| GeneID | 3484 |
| Immunogen | A synthetic peptide corresponding to a sequence within amino acids 160-259 of human IGFBP1 (P08833). |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human |
| SWISS | P08833 |
| Protein Weight | 28kDa |
| Shipping | Ice bag |
Biological Background: IGFBP1 Function and Localization
- Insulin-like growth factor-binding protein 1 (IGFBP1), also known as placental protein 12 (PP12), is a secreted multifunctional protein that modulates the bioavailability of IGF1 and IGF2, thereby regulating cell migration, proliferation, differentiation, and apoptosis in a cell-type-specific manner. Related references: PMID:11397844 PMID:15972819
- Through its RGD motif, IGFBP1 binds integrin ITGA5:ITGB1, promoting cell migration by activating focal adhesion kinase (FAK) and the mitogen-activated protein kinase (MAPK) pathway. Related references: PMID:7504269
- IGFBP1 is highly expressed in the placenta and liver and is classified as a secreted protein following cleavage of its N-terminal signal peptide.
- Post‑translational modifications include phosphorylation and disulfide bond formation, which may influence its binding affinity and functional activity.
- The protein has a predicted molecular weight of approximately 28 kDa, consistent with the 27.9 kDa calculated from its amino acid sequence.
- Structural studies (3D-structure) and direct protein sequencing have confirmed its primary sequence and folding, providing a basis for epitope mapping and antibody development.
Experimental Guidance and Technical Tips
- The immunogen (aa 160–259) lies in a central region of human IGFBP1; this epitope may recognize both unmodified and post‑translationally modified forms.
- For Western blot analysis, the expected band migrates near 28 kDa; validate antibody specificity using positive and negative cell lysates.
- For ELISA, consider paired antibody formats (e.g., sandwich) and titrate concentrations to achieve optimal signal-to-noise ratios in your sample matrix.
- As the antibody is recommended for human samples, cross-reactivity with other species should be tested if needed.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio offers comprehensive IVD raw material supply solutions, connecting diagnostic manufacturers and research laboratories with high-quality reagents like this anti‑IGFBP1 monoclonal antibody for growth factor and metabolic disorder research. Our capabilities include validated monoclonal/polyclonal antibodies, optimized matched antibody pairs, bulk ancillary reagents, and custom sourcing for rare targets. Partner with CamelBio to streamline your transition from early-stage assay development to reliable diagnostic application.
Product Datasheet
Anti-IGFBP1 Monoclonal Antibody for WB, ELISA - P08833
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!